Prospective, non-randomised, open-label study of UDP-gluconoryltransferase (UGT) 2B17 genotype as a predictive marker of exemestane pharmacokinetics (PK) in post-menopausal hormone receptor (HR)-positive Asian metastatic breast cancer (MBC) patients progressing after prior endocrine therapy.

Alip, AB (2015) Prospective, non-randomised, open-label study of UDP-gluconoryltransferase (UGT) 2B17 genotype as a predictive marker of exemestane pharmacokinetics (PK) in post-menopausal hormone receptor (HR)-positive Asian metastatic breast cancer (MBC) patients progressing after prior endocrine therapy. European Journal of Cancer, 51. S295-S296.

[img] PDF
Exemestane study publication 2015_poster.pdf

Download (317kB)

Abstract

-

Item Type: Article
Uncontrolled Keywords: Prospective, non-randomised, open-label study of UDP-gluconoryltransferase (UGT) 2B17 genotype as a
Subjects: R Medicine
Depositing User: MR. ADNAN YAHYA
Date Deposited: 30 Dec 2015
Last Modified: 30 Dec 2015
URI: http://repository.um.edu.my/id/eprint/108485

Actions (login required)

View Item View Item